Showing results (341-350 of 414) with videos related to
Sort By:
Pageof 42
The Journal of Urology|August 1, 1976
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostateW W Scott, R P Gibbons, D E Johnson, et al.Cancer|September 1, 1994
Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection ProjectC Mettlin, P J Littrup, R A Kane, et al.The Journal of Urology|August 1, 1986
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of SurgeonsJ D Schmidt, C J Mettlin, N Natarajan, et al.Cancer|May 15, 1985
Estrogen and progestin receptors in human prostatic carcinomaR M Wolf, S L Schneider, J E Pontes, et al.The Prostate|March 1, 1995
Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargementG P Murphy, E H Holmes, A L Boynton, et al.CA: a Cancer Journal for Clinicians|August 13, 1999
Clinical highlights from the National Cancer Data Base, 1999A M Fremgen, K I Bland, L S McGinnis, et al.The Prostate|January 1, 1980
Fundamental biochemical and immunological aspects of prostatic acid phosphataseM F Lin, C L Lee, J W Wojcieszyn, et al.The Prostate. Supplement|January 1, 1996
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patientsE H Holmes, T G Greene, W T Tino, et al.Surgery, Gynecology & Obstetrics|June 1, 1986
Risk factors and current management in carcinoma of the endometriumJ T Wharton, J J Mikuta, C Mettlin, et al.Journal of the National Cancer Institute|January 1, 1981
Prostate antigen: a marker for human prostate epithelial cellsL D Papsidero, M Kuriyama, M C Wang, et al.Pageof 42